Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
 
  Phillip Investor Notes

27-06-2024(Thu) 26-06-2024(Wed) 25-06-2024(Tue) 24-06-2024(Mon) 21-06-2024(Fri)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
9 Jan, 2024 (Tuesday)

            
SHINEWAY PHARM(2877)
Analysis¡G
SHINEWAY PHARMACEUTICAL GROUP (2877) is primarily engaged in the research, manufacture and sales of traditional Chinese medicine (¡§TCM¡¨) including injection products, soft capsule products and granule products. The Group continues to focus on the development strategy of oral products, including exclusive oral products such as Huamoyan Granule, Huamoyan Capsule, Qi Huang Tong Mi Granule, Jiang Zhi Tong Luo Soft Capsule and exclusive oral dosage form products such as Qing Kai Ling Soft Capsule and Huo Xiang Zheng Qi Soft Capsule. As at 30 June 2023, the Group regularly manufactured a total of 18 medications which are listed on the National Essential Drug List. The government`s promotion of the widespread use of essential drugs will drive the sustained growth of the Group`s prescription medications and OTC Medications which are included in the National Essential Drug List. The Group`s TCM formula granules continues to grow rapidly. Its production capacity of TCM formula granules has reached an annual production value of RMB5 billion. In the future, the Group will continue to implement its production capacity expansion plan based on market development status. In terms of Chinese Medicine Injection, the Group`s Qing Kai Ling Injection, Shen Mai Injection, Shu Xue Ning Injection and Guan Xin Ning Injection won the bid in each of the national and provincial centralized TCM procurements in recent years. For the nine months ended 30 September 2023, the turnover of the Group was RMB 3,472 million, representing an increase of 21.9% as compared with the same period of 2022. As of 30 June 2023, calculating based on the total issued shares of 827,000,000, net cash per share of the Group amounted to HKD7.03, and net assets per share amounted to HKD8.70. (I do not hold the above stock)
Strategy¡G
Buy-in Price: $7.60, Target Price: $8.40, Cut Loss Price: $7.20


Sanmei(603379)
Analysis¡G
Sanmei Chem mainly produces fluorocarbon chemicals and inorganic fluorine products, and is one of the leading enterprises in fluorine chemical industry. From January to September 2023, the company achieved a revenue of 2.609 billion yuan, a yoy decrease of -30.76%, and a net profit attributable to the parent company of 238 million yuan, a yoy decrease of -4.45%. The main reason for the decline in the Company`s performance was the insufficient downstream demand, which led to a decline in the quantity and price of its core product, fluorine based refrigerants. On October 24, 2023, the government issued the "2024 Total Quota Setting and Allocation Plan for Hydrofluorocarbons", officially implementing the supply constraints of third-generation refrigerants. The situation of oversupply is expected to gradually improve, refrigerant prices have entered the growth range, and the profitability of leading enterprises is expected to continue to recover.
Strategy¡G
Buy-in Price: RMB33.70, Target Price: RMB39.50, Cut Loss Price: RMB30.00



Report Review of December 2023

Sectors:

Air & Automobiles (Zhang Jing),

TMT, Semiconductors, Consumer, Healthcare (Eric Li)

Energy, Consumer (Judy Li)

Automobile & Air (ZhangJing)

This month I released 3 updated reports of Tianqi(002466.CH), GWM (2333.HK), and Weichai(2338.HK).

Since the beginning of this year, as affected by supply-demand mismatch and destocking of the industry chain, the prices of lithium salt plunged from RMB500 thousand per ton last year to approximately RMB100 thousand per ton. Consequently, Tianqi Lithium recorded an operating revenue of RMB8,576 million in Q3, which fell by 17.14% yoy and by 35.88% qoq. Its net profit attributable to shareholders amounted to RMB1,646 million, which decreased by 70.89% yoy and increased by 4.38% qoq. Nevertheless, thanks to its complete self-sufficiency of the raw material, lithium concentrates, the Company enjoys advantages in cost control and vertical integration of the industry chain and its gross margin remains high. Specifically, the gross margin in the first three quarters and Q3 reached 86.6% and 85.23%, with a yoy increase of 1.1 and a yoy decrease of 2.1 ppts, respectively. We predict that lithium prices may still experience low fluctuations in the short term. However, high growth of and cost support and preferential policies for the downstream industries, especially new energy vehicles, shipping, and energy conservation, are promising in medium and long term. The fundamentals of the lithium industry are likely to achieve sustained, sound growth in the next few years. The Company has made the layout of the best lithium resources worldwide, practiced a vertical integrated business model, and achieved the 100% self-sufficiency of lithium concentrates. In combination of the advanced production and processing of lithium compounds, it can maximise the profit margin of lithium products, and will continue to consolidate its leading position based on its future capacity expansion.

GWM has been deepening new energy and intelligent transformation, adjusting the product mix and increasing investments in brand and channel building since H2 of last year, and has realized the flat, network-based and decentralized layout covering the entire industrial chain in new energy and intelligence sectors. Meanwhile, it continued to invest in the R&D in the fields of new energy and intelligence, and rolled out new models with DHT and the brand-new Hi4 technology, such as All-New Haval H5, Haval 2nd Generation Big Dog PHEV, Haval Menlong, Haval Xiaolong, WEY Lanshan, WEY Gaoshan, TANK 400Hi4-T and TANK 500Hi4-T, by the end of last year. As of late October, the Company has unveiled 10 new models this year, including 8 plug-in hybrid models. In the next step, it will roll out new energy models such as TANK 300 Hi4-T, New Haval Xiaolong MAX, New WEY Latte, Lanshan's advanced edition with intelligent driving and Ora Lighting Cat Dark Night Edition. The gross profit margin decreased by 1 percentage point yoy to 20.6%, mainly due to the favorable exchange direction in 2022H1, resulting in a higher base. In addition, due to GWM's increased R&D investment in the first half of the year to ensure its ability to undertake orders, the proportion of revenue increased from 1.9 ppts to 8.9% compared to the same period last year. During the period, the profit attributable to shareholders was RMB 150 million, a slight increase of 1% yoy. The net profit attributable to shareholders ratio was 5.9%, a decrease of 1.5 ppts yoy.

If the additional increase in R&D investment is not included, the operating profit margin will actually increase slightly by 0.5% compared to 2022H1. The Management pointed out that the peak period of R&D investment in the first half of the year has passed, and in the future, it will return to the normal revenue proportion level of around 7%. The expense ratio level is expected to improve in the second half of the year. We believe that the Company's current strategy of increasing R&D investment and competing for more market share may put pressure on profit margins in the short term, but it provides a foundation for long-term competitive and sustainable development. H6 Midterm Modified Edition, a sedan of WEY and TANK 700/800 will also be included in the brand matrix in the future. Driven by new models, Great Wall Motor sold 170 thousand new energy models accumulatively in the first three quarters, accounting for 19.7% of the total, up 7.4 ppts from 12.3% for 2022.

As natural gas prices are dramatically lower than diesel prices, natural gas-fueled heavy trucks have emerged to be the most eye-catching segment during the recovery of the heavy truck industry this year. The cumulative domestic sales of natural gas-fuelled heavy trucks from January to September amounted to 107.4 thousand, up 255% yoy. Weichai has been the leader of engines for natural gas-fueled heavy trucks in China, with a market share of nearly 70%. Additionally, the export of heavy trucks has maintained a fast growth this year. Statistically, 210 thousand heavy trucks were exported from January to September, up 70% yoy, which represented up to 30% of the total exports and hit a record high.

Thanks to several favorable factors, Weichai Power sold 548 thousand engines in the first three quarters, which climbed by 24.5% yoy. Particularly, 52 thousand of them were exported, with a year-on-year increase of 35.6%. In terms of commercial vehicle business, Shaanxi Heavy Duty Automotive Co., Ltd. (Shaanxi Zhongqi), a controlling subsidiary of the Company, sold 92 thousand heavy trucks in the first three quarters, up 52% yoy, wherein 42 thousand were exported with a year-on-year increase of 71.9%. In regard to intelligent logistics business, KION Group AG (KION), a controlling subsidiary of the Company, recorded the net profit before interest and tax of EUR570 million in the first three quarters, which jumped by 171.6% yoy. As shown in its 2023 A-share Restricted Equity Incentive Plan Draft released, the target values of revenue for 2024, 2025, and 2026 are RMB210.2 billion, RMB231.2 billion, and RMB258.9 billion, respectively. The EBT margin is 8%, 9%, and 9%, respectively, and the EBT target are RMB16.8 billion, RMB20.8 billion, and RMB23.3 billion. The above objectives exceed market expectations, indicating the Company's great confidence in its future growth ratio.

Energy, Consumer (Judy Li)

This month I released reports of Satellite Chemical Co., Ltd. (002648.SZ).

The company is a leading integrated manufacturer of light hydrocarbon industry chain in China, focusing on three major fields: functional chemicals, new polymer materials, and new energy materials. It owns the first imported ethane comprehensive utilization unit, the first propane dehydrogenation unit, The largest acrylic production facility in China, with production capacity of HDPE (high-density polyethylene), EO (ethylene oxide), EG (electro-galvanizing), SAP (super absorbent resin), polyether macromonomer, hydrogen peroxide and other products Ranking at the forefront in the country, its products are widely used in aerospace, new energy vehicles, electronic chips, agriculture and forestry maintenance, health care and other fields.

In the first half of 2023, the company achieved operating income of 20.014 billion yuan, a year-on-year increase of 6.38%. The net profit attributable to the parent company was RMB 1.843 billion, a year-on-year decrease of 34.13%. Achieved non-net profit of RMB 1.952 billion, a year-on-year decrease of 28%. The gross profit margin was 17.51%, a year-on-year decrease of 6.97 percentage points. The net profit margin was 9.20%, a year-on-year decrease of 5.64 percentage points. Among them, revenue in the second quarter was 10.599 billion yuan, a year-on-year decrease of 0.72% and a month-on-month increase of 12.57%. The net profit attributable to the parent company was 1.136 billion yuan, a year-on-year decrease of 9.87% and a month-on-month increase of 60.59%. Achieved non-net profit of RMB 1.17 billion, a year-on-year increase of 1% and a month-on-month increase of 51%. The gross profit margin was 18.62%, a year-on-year decrease of 2.37 percentage points and a month-on-month increase of 2.35 percentage points. The net profit margin was 10.71%, a year-on-year decrease of 1.1 percentage points and a month-on-month increase of 3.22 percentage points.

The company's Pinghu base new materials and new energy integration project is planned to be operational by the end of 2023. The annual output of 360,000 tons of acrylic acid and 720,000 tons of ester technological transformation projects, 300,000 tons of polypropylene and 250,000 tons of hydrogen peroxide projects will make more efficient use of PDH's propylene Resources produce multi-carbon alcohols, forming a closed industrial chain of propylene-acrylic acid-acrylate. According to information from Baichuan Yingfu, China's actual acrylic acid consumption will reach 2.415 million tons in 2022, a year-on-year increase of 23.4%, and the CAGR in the past five years has reached 10.3%. In 2022, the proportion of CR5 in the acrylic acid industry will reach 60.9%, and the industry concentration is high. Among them, satellite chemicals have a market share of 18.9%, ranking the industry leader. The company has sufficient reserves of projects under construction, and its future growth potential is expected to be gradually realized.

Click Here for PDF format...




Writer Info
Research Team
Tel: + (852) 2277 6555
Email:
research@phillip.com.hk

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2024 Phillip Securities (HK) Ltd. All Rights Reserved.


Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]